Santé Ventures, an early-stage life science venture capital firm, announces a $2.6 million Series A investment in TVA Medical, Inc. (TVA), a medical device company developing minimally invasive therapies for End-Stage Renal Disease (ESRD). Santé formed the new company in partnership with TVA Founder, William (Billy) Cohn, MD, a cardiovascular surgeon and the Director of Minimally Invasive Surgical Technology at the Texas Heart Institute (THI) at St. Luke’s Episcopal Hospital in Houston, Texas. Cohn has [...]